Over 25 years, ZS Associates has helped clients in more than 70 countries measurably improve their results, through our comprehensive expertise in sales and marketing consulting, capability building, and outsourcing. Our clients include multinational, midsize and entrepreneurial companies around the world, with a deep and long-standing emphasis on the healthcare sector, and the pharma/biotech sector in particular. Through our business development and licensing practice area, we support both large and small pharma/biotech companies with services ranging from strategic portfolio evaluation and business development strategy to evaluation of specific potential partners and deals. ZS has more than 1,000 professionals serving clients from 17 offices worldwide.

Eli Lilly and Company is a leading, innovation-driven
corporation committed to developing a growing portfolio of
best-in-class and first-in-class pharmaceutical products that
help people live longer, healthier, and more active lives. Lilly products treat
depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes,
osteoporosis, and many other conditions. Founded in 1876, Lilly now
employs more than 41,000 people worldwide and markets its medicines in
143 countries. It has major research and development facilities in nine
countries and manufacturing facilities in 13 countries - and also conducts
clinical trials in more than 50 countries. Lilly is committed to providing
answers that matter - through medicines and information - for some of the
world's most urgent medical needs.

Dean & Company is a strategy consulting firm with a unique mix of both traditional business strategy work and a range of investing activities for large corporations, technology start-ups, and equity funds. We work with senior executives to dramatically improve and sustain their company's performance. Dean & Company has an established, highly successful track record in generating actionable and quantifiable results for our clients in the Life Sciences. These include a number of the largest global companies as well as emerging leaders in the Pharmaceuticals, Biotechnology, and Medical Devices & Technology industries. We additionally have developed specialized expertise in the Vaccines industry. The hallmark of our work in life sciences, as in other industries, is our ability to deliver highly quantitative, analytic-driven solutions to complex business problems and the development of practical, action-oriented
recommendations and their associated measurable impact on the bottom-line. Our life sciences capabilities extend across the following industry challenges and issues: Licensing/Strategic Alliances/M&A Due Diligence, Portfolio/Life Cycle Management, Product Commercialization & Launch, Manufacturing & Distribution Strategy, Competitive Intelligence/Benchmarking, Marketing Strategy, Pricing & Reimbursement, R&D Productivity.

IntraLinks provides enterprise-class solutions which facilitate the secure, compliant and auditable exchange of critical information, collaboration and workflow management inside and outside the enterprise. Our on-demand solutions help you organize, manage, share and track information, enabling you to accelerate your workflow, optimize your business processes and realize new profit potential. Since 1997, IntraLinks has been used on critical business processes by more than 750,000 users from 90,000 organizations worldwide, including 10 of the top 10 pharmaceutical companies and hundreds of biotechs. IntraLinks counts 800 of the Fortune 1000 as clients, including enterprises such as AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the FDIC.

EvaluatePharma® is the premier source for commercial analysis of the pharma and biotech sector. We help our clients to find value in the sector through indispensable, incisive and innovative global analysis.

EvaluatePharma sets the standards for consensus forecasts for the pharma and biotech industries. Our expertise and innovative approach has led to other pioneering developments including Merge Company tool, Calendar of Events and the EventAnalyzer, and interactive NPV Analyzer.

We offer our clients analysis and insights not available anywhere else. EvaluatePharma is relied on by the top global pharma and biotech companies, the investment community and global management consulting firms.

Sanofi-Aventis, a leading global pharmaceutical company, discovers, develops, and distributes therapeutic solutions to address the world’s expanding healthcare needs. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With approximately 100,000 dedicated professionals in more than 100 countries, sanofi-aventis is devoted to advancing healthcare around the world. We are committed to maintaining the innovative approach to pharmaceuticals established by our parent company, headquartered in Paris, France. Our U.S. affiliate, with headquarters in Bridgewater, New Jersey, employs approximately 15,000 professionals located throughout the country. Sanofi-aventis, U.S. is a dynamic healthcare organization working to meet the needs of physicians and their patients. At sanofi-aventis, each and every day we work for what really matters: health .For more information, visit www.sanofi-aventis.us

i3 Pharma Informatics combines unparalleled data assets, online tools, and scientific expertise to help you attain a clearer understanding of your products’ potential and corresponding market dynamics—so you can make more rapid, informed decisions throughout development and commercialization.

As a division of UnitedHealth Group, we have exclusive access to one of the largest, most robust and detailed single research databases in the world containing de-identified patient-level information on millions of individuals from multiple health plans.